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Background
MR-guided electrophysiology (MR-EP) for the treatment
of arrhythmia has the potential advantages of improved
soft tissue contrast navigation and visualization of abla-
tion-induced tissue changes. In the past, the development
of MR-conditional EP catheters and an appropriate
image guidance platform have represented major obsta-
cles. The aim of this work was to establish and evaluate a
catheter-guided approach that allows monitoring of
radiofrequency (RF) ablation at the electrode tip.
Methods
A deflectable ablation catheter (Vision MRM, Imricor,
Burnsville, MN) with two RF micro-coils allows tracking
of the catheter tip and its orientation. The integration of
dedicated transmission line technology ensures safe
tracking. Continuous acquisition of projections allows
tracking of the catheter motion with an update rate of
10Hz. A prototype platform (MR iSuite) was used to dis-
play the position and the orientation of the catheter tip
relative to multi-planar reformatted or real-time slices
and to a surface-rendered cardiac model in 3D (Figure
1a) for improved catheter guidance. The iSuite allows
automatic planning of MR scans relative to the position
and orientation of the catheter. This mechanism was
used to invoke the acquisition of two different image
datasets on a 1.5T MR-scanner (Achieva, Philips Health-
care, Netherlands) to prepare and monitor RF ablation.
First, a cardiac-gated SSFP cine sequence (TR/TE=3.2/
1.6ms, 40 phases, resolution: 1.4x1.4x8mm, AQ=15sec) is
obtained to verify sufficient contact of the catheter tip to
the tissue. Secondly, a high-resolution cardiac-triggered
black blood T2-weighted TSE sequence (TE=50ms,
Turbo-Factor=16, resolution: 0.95x0.95x4mm, AQ=12sec)
is used to visualize the effect of the RF ablation on the
tissue (edema and wall-thickness).
This approach was first tested in a phantom and then
assessed in-vivo in a 40kg pig. Four discrete RF lesions
(40W, 1min) were applied on the posterior right atrial
wall. Edema and wall thickness were monitored for each
catheter tip location over the first 5min and at 15, 30,
and 45min. The T2-signal in the wall was normalized to
the ventricular myocardial signal to determine a relative
enhancement.
Results
Catheter tracking at 10Hz was reliable for all catheter
tip orientations, resulting in smooth catheter guidance
and accurate automatic scan plane planning.
The in-vivo results are shown in Figure 1. The position
of the catheter tip (Figure 1b) is confirmed by cardiac
cine SSFP imaging (Figure 1c). The images for measure-
ment of the wall thickness and the signal enhancement
are shown in Figure 1d+e, before and 30min after abla-
tion. The wall thickness and T2-signal enhancement at
two ablation sites increase to approx. twice the original
value during the first 30min (Figure 1f+g).
Conclusions
A new technique to quantify wall thickness and T2-sig-
nal enhancement at the catheter tip has been demon-
strated. This allows for fast and efficient monitoring of
catheter-based RF ablation.
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Figure 1 Catheter tip is displayed relative to multi-planar reformatted slices and a surface-rendered cardiac model (a). The catheter tip position
obtained from tracking (b) and verified visually in a SSFP cine scan (c). Wall thickness and T2-signal of SVC, IVC before and 40 min after ablation
(d,e). Wall thickness and T2-signal enhancement over time (f,g).
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